KOLTE PATIL DEV. LTD.

256.8 -2.77 (-1.08%) Buy

KOLTEPATIL investors not showing any loss of confidence as it pauses to catch its breath

13 min read

KOLTE PATIL DEV. LTD. underperformed broader market on Tuesday. It returned -1.08% to close at 256.8. On a day when the overall market breadth was 70%, it closed higher than 68% of the market. In comparison, the benchmark NIFTY-50 index closed today at -0.0036%.

[Themes containing KOLTEPATIL]

Buy-and-Hold investors in KOLTEPATIL experienced a maximum drawdown of -10.31% over the last three months. It returned +20.65% during this strong up trending period. There were both Long and Short signals during this period, while the long signals were significantly more profitable than the short signals.

Trend

KOLTEPATIL has been outperforming the NIFTY-50 index in recent time. Over the last 3 years and 1 month, KOLTEPATIL outperformed the NIFTY-50 index on 43% days. Which indicates that on days KOLTEPATIL outperforms the NIFTY-50 index, it's performance is marginally better than on the days it underperforms the NIFTY-50 index.

During the last three months KOLTEPATIL delivered losses on 59% days. However, it still managed to end this period in a profit. It's best return during this period (of +9.85%) was on Wednesday, 19 Dec, 2018. While it's worst loss in the same period (of -3.18%) was on Thursday, 20 Dec, 2018. There was initially a bullish trend during this period which started on 23 Oct, 2018 and went on till 29 Oct, 2018. The bullish trend returned +15.01% to investors. This was followed by a bearish trend that started on 22 Nov, 2018 and ended on 29 Nov, 2018. This bearish trend lost -4.49% of investor capital.

On monthly basis, KOLTEPATIL delivered losses in more months over the last year, than profits. KOLTEPATIL delivered profits less regularly than NIFTY-50 index. KOLTEPATIL was also a more risky investment than NIFTY-50 index as it's worst month in the last year, Sep 2018, returned -21.95% compared to -6.42% returned by NIFTY-50 index in Sep 2018. KOLTEPATIL had a longer winning streak of losing months than NIFTY-50 index. It went down in 3 straight months (from May 2018 to Jul 2018) during which period it delivered -20.0%. It is interesting to note that both KOLTEPATIL and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

There's more honor in investment management than in investment banking.
-- Charlie Munger

KOLTEPATIL is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant fall in KOLTEPATIL's volatility from 23 Oct, 2018 to 5 Dec, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that KOLTEPATIL has significant negative skewness in it's return distribution. This indicates that KOLTEPATIL is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than KOLTEPATIL. Therefore, NIFTY-50 must receive a lower allocation than KOLTEPATIL in your portfolio. NIFTY-50 index usually has shorter drawdown period than KOLTEPATIL.

Based on your interest in KOLTEPATIL you may find it interesting to know that TORNTPHARM, INFY and BRITANNIA are large caps that have all shown remarkable performance and qualify to be on every investor's watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter